{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:05:56Z","timestamp":1789589156198,"version":"build-2803163510"},"reference-count":54,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["European Clinical Respiratory Journal"],"published-print":{"date-parts":[[2016,1,1]]},"DOI":"10.3402\/ecrj.v3.31780","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T06:24:39Z","timestamp":1471328679000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["No change in prevalence of symptoms of COPD between 1996 and 2006 in Finnish adults \u2013 a report from the FinEsS Helsinki Study"],"prefix":"10.1080","volume":"3","author":[{"given":"Annette","family":"Kainu","sequence":"first","affiliation":[{"name":"HUCH Heart and Lung Center, Peijas Hospital, Helsinki University Hospital and University of Helsinki","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Pallasaho","sequence":"additional","affiliation":[{"name":"Espoo City Health Services","place":["Espoo, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pietinalho","sequence":"additional","affiliation":[{"name":"Raasepori Health Center","place":["Raasepori, Finland"]},{"name":"Finnish Lung Health Association","place":["Helsinki, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030442"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61380-4"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00003609"},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"Svanes C Sunyer J Plana E Dharmage S Heinrich J Jarvis D etal. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010; 65: 14\u201320. [PubMed Abstract].","DOI":"10.1136\/thx.2008.112136"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"Miravitlles M Soriano JB Garcia-Rio F Munos L Duran-Tauleria E Sanchez G etal. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009; 64: 863\u20138. [PubMed Abstract].","DOI":"10.1136\/thx.2009.115725"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"Feenstra TL van Genugten ML Hoogenveen RT Wouters EF Rutten-van M\u00f6lken MP etal. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med. 2001; 164: 590\u20136. [PubMed Abstract].","DOI":"10.1164\/ajrccm.164.4.2003167"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2003.1446"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.062802"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040112"},{"key":"e_1_3_1_11_1","doi-asserted-by":"crossref","unstructured":"Fabricius P L\u00f8kke A Marott JL Vestbo J Lange P. Prevalence of COPD in Copenhagen. Respir Med. 2011; 105: 410\u20137. [PubMed Abstract].","DOI":"10.1016\/j.rmed.2010.09.019"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046746"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"Vasankari TM Impivaara O Heli\u00f6vaara M Hestaro S Liippo K Puukka P etal. No increase in the prevalence of COPD in two decades. Eur Respir J. 2010; 36: 766\u201373. [PubMed Abstract].","DOI":"10.1183\/09031936.00178109"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp10X514729"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"Soriano JB Ancochea J Miravitlles M Garcia-Rio F Duran-Tauleria E Munos L etal. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997\u20132007. Eur Respir J. 2010; 36: 758\u201365. [PubMed Abstract].","DOI":"10.1183\/09031936.00138409"},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"Ford ES Croft JB Mannino DM Wheaton AG Zhang X Giles WH. COPD surveillance \u2013 United States 1999\u20132011. Chest. 2013; 144: 284\u2013305. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1378\/chest.13-0809"},{"key":"e_1_3_1_17_1","doi-asserted-by":"crossref","unstructured":"Kim TB Oh YM Chang YS Cho YS Jang AS Cho SH etal. COREA and KOLD Study Group. The reality of an intermediate type between asthma and COPD in practice. Respir Care. 2012; 57: 1248\u201353. [PubMed Abstract].","DOI":"10.4187\/respcare.01232"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062985"},{"key":"e_1_3_1_19_1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis Management and Prevention of COPD. 2015. Available from: http:\/\/www.goldcopd.org\/ [cited 9 November 2015]."},{"key":"e_1_3_1_20_1","doi-asserted-by":"crossref","unstructured":"Schermer TR Smeele IJ Thoonen BP Lucas AE Grootens JG van Boxem TJ etal. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J. 2008; 32: 945\u201352. [PubMed Abstract].","DOI":"10.1183\/09031936.00170307"},{"key":"e_1_3_1_21_1","doi-asserted-by":"crossref","unstructured":"Bakke PS R\u00f6nmark E Eagan T Pistelli F Annesi-Maesano I Maly M etal. Recommendations for epidemiological studies on COPD. ERS Task Force Report. Eur Respir J. 2011; 38: 1261\u201377. [PubMed Abstract].","DOI":"10.1183\/09031936.00193809"},{"key":"e_1_3_1_22_1","doi-asserted-by":"crossref","unstructured":"Roberts SD Farber MO Knox KS Phillips GS Bhatt NY Mastronarde JG etal. FEV1\/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest. 2006; 130: 200\u20136. [PubMed Abstract].","DOI":"10.1378\/chest.130.1.200"},{"key":"e_1_3_1_23_1","doi-asserted-by":"crossref","unstructured":"Hansen JE Sun X-G Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1\/FVC ratio below the fifth percentile not <70%. Chest. 2007; 131: 349\u201355. [PubMed Abstract].","DOI":"10.1378\/chest.06-1349"},{"key":"e_1_3_1_24_1","doi-asserted-by":"crossref","unstructured":"Cerveri I Corsico AG Accordini S Niniano R Ansaldo E Ant\u00f3 JM etal. Underestimation of airflow obstruction among young adults using FEV1\/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax. 2008; 63: 1040\u20135. [PubMed Abstract].","DOI":"10.1136\/thx.2008.095554"},{"key":"e_1_3_1_25_1","doi-asserted-by":"crossref","unstructured":"Swanney MP Ruppel G Enright PL Pedersen OF Crapo RO Miller MR etal. Using the lower limit of normal for the FEV1\/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63: 1046\u201351. [PubMed Abstract].","DOI":"10.1136\/thx.2008.098483"},{"key":"e_1_3_1_26_1","doi-asserted-by":"crossref","unstructured":"Miller MR Quanjer PH Swanney MP Ruppel G Enright PL. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest. 2011; 139: 52\u20139. [PubMed Abstract].","DOI":"10.1378\/chest.10-0189"},{"key":"e_1_3_1_27_1","doi-asserted-by":"crossref","unstructured":"Pallasaho P Lundb\u00e4ck B Meren M Kiviloog J Loit H-M Larsson K etal. Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki Stockholm and Tallinn. Respir Med. 2002; 96: 759\u201369. [PubMed Abstract].","DOI":"10.1053\/rmed.2002.1308"},{"key":"e_1_3_1_28_1","doi-asserted-by":"crossref","unstructured":"Bjerg A Ekerljung L Middelveld R Dahl\u00e9n SE Forsberg B Franklin K etal. Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA2LEN surveys. PLoS One. 2011; 6: e16082. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1371\/journal.pone.0016082"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2013.830095"},{"key":"e_1_3_1_30_1","doi-asserted-by":"crossref","unstructured":"Lindberg A Bjerg-B\u00e4cklund A R\u00f6nmark E Larsson L-G Lundb\u00e4ck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2006; 100: 264\u201372. [PubMed Abstract].","DOI":"10.1016\/j.rmed.2005.04.029"},{"key":"e_1_3_1_31_1","doi-asserted-by":"crossref","unstructured":"Kainu A Rouhos A Sovij\u00e4rvi A Lindqvist A Sarna S Lundb\u00e4ck B. COPD in Helsinki Finland: socioeconomic status based on occupation has an important impact on prevalence. Scand J Public Health. 2013; 41: 570\u20138. [PubMed Abstract].","DOI":"10.1177\/1403494813484554"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdq031"},{"key":"e_1_3_1_33_1","doi-asserted-by":"crossref","unstructured":"Falzon C Soljak M Elkin SL Blake ID Hopkinson NS. Finding the missing millions \u2013 the impact of a locally enhanced service for COPD on current and projected rates of diagnosis: a population-based prevalence study using interrupted time series analysis. Prim Care Respir J. 2013; 22: 59\u201363. [PubMed Abstract].","DOI":"10.4104\/pcrj.2013.00008"},{"key":"e_1_3_1_34_1","doi-asserted-by":"crossref","unstructured":"Kainu A Pallasaho P Piiril\u00e4 P Lindqvist A Sovij\u00e4rvi A Pietinalho A. Increase in prevalence of physician-diagnosed asthma in Helsinki during the Finnish Asthma Programme: improved recognition of asthma in primary care? A cross-sectional cohort study. Prim Care Respir J. 2013; 22: 64\u201371. [PubMed Abstract].","DOI":"10.4104\/pcrj.2013.00002"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5213.1665"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.93.04030257"},{"key":"e_1_3_1_37_1","doi-asserted-by":"crossref","unstructured":"Pallasaho P Lundb\u00e4ck B L\u00e4sp\u00e4 SL Kotaniemi J Sovij\u00e4rvi ARA Laitinen LA. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki study. Respir Med. 1999; 93: 798\u2013809. [PubMed Abstract].","DOI":"10.1016\/S0954-6111(99)90265-2"},{"key":"e_1_3_1_38_1","doi-asserted-by":"crossref","unstructured":"Dales RE Mehdizadeh A Aaron SD Vandemheen KL Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J. 2006; 28: 319\u201322. [PubMed Abstract].","DOI":"10.1183\/09031936.06.00138105"},{"key":"e_1_3_1_39_1","doi-asserted-by":"crossref","unstructured":"Von Hertzen L Reunanen A Impivaara O M\u00e4lki\u00e4 E Aromaa A. Airway obstruction in relation to symptoms in chronic respiratory disease \u2013 a nationally representative population study. Respir Med. 2000; 94: 356\u201363. [PubMed Abstract].","DOI":"10.1053\/rmed.1999.0715"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00158781"},{"key":"e_1_3_1_41_1","doi-asserted-by":"crossref","unstructured":"Langhammer A Johnsen R Holmen J Gulsvik A Bjermer L. Cigarette smoking gives more respiratory symptoms among women than men. The Nord-Tr\u00f8ndelag Health Study (HUNT). J Epidemiol Community Health. 2000; 54: 917\u201322. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1136\/jech.54.12.917"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.122002"},{"key":"e_1_3_1_43_1","doi-asserted-by":"crossref","unstructured":"Juusela M Pallasaho P R\u00f6nmark E Sarna S Sovij\u00e4rvi A Lundb\u00e4ck B. Dose-dependent association of smoking and bronchial hyperresponsiveness. Eur Respir J. 2013; 42: 1503\u201312. [PubMed Abstract].","DOI":"10.1183\/09031936.00073712"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/15412550500218122"},{"key":"e_1_3_1_45_1","doi-asserted-by":"crossref","unstructured":"Guerra S Sherrill DL Venker C Ceccato CM Halonen M Martinez FD. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax. 2009; 64: 894\u2013900. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1136\/thx.2008.110619"},{"key":"e_1_3_1_46_1","doi-asserted-by":"crossref","unstructured":"Watson L Schouten JP L\u00f6fdahl C-G Pride NB Laitinen LA Postma DS. Predictors of COPD symptoms: does the sex of the patient matter?. Eur Respir J. 2006; 28: 311\u20138. [PubMed Abstract].","DOI":"10.1183\/09031936.06.00055805"},{"key":"e_1_3_1_47_1","doi-asserted-by":"crossref","unstructured":"Kessler R Partridge MR Miravitlles M Cazzola M Vogelmeier C Leynaud D etal. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011; 37: 264\u201372. [PubMed Abstract].","DOI":"10.1183\/09031936.00051110"},{"key":"e_1_3_1_48_1","doi-asserted-by":"crossref","unstructured":"Schlecht NF Schwartzman K Bourbeau J. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2005; 2: 183\u201391. [PubMed Abstract].","DOI":"10.1191\/1479972305cd079oa"},{"key":"e_1_3_1_49_1","doi-asserted-by":"crossref","unstructured":"Barr RG Herbstman J Speizer FE Camargo CAJr.. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol. 2002; 155: 965\u201371. [PubMed Abstract].","DOI":"10.1093\/aje\/155.10.965"},{"key":"e_1_3_1_50_1","doi-asserted-by":"crossref","unstructured":"Hanania NA Mannino DM Yawn BP Mapel DW Martinez FJ Donohue JF etal. Predicting risk of airflow obstruction in primary care: validation of the lung function questionnaire (LFQ). Respir Med. 2010; 104: 1160\u201370. [PubMed Abstract].","DOI":"10.1016\/j.rmed.2010.02.009"},{"key":"e_1_3_1_51_1","doi-asserted-by":"crossref","unstructured":"Mintz ML Yawn BP Mannino DM Donohue JF Hanania NA Grellet CA etal. Prevalence of airway obstruction assessed by Lung Function Questionnaire. Mayo Clin Proc. 2011; 86: 375\u201381. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.4065\/mcp.2010.0787"},{"key":"e_1_3_1_52_1","unstructured":"Available from: www.savutonsuomi.fi\/en.php [cited 20 March 2016].."},{"key":"e_1_3_1_53_1","doi-asserted-by":"crossref","unstructured":"Kinnula VL Vasankari T Kontula E Sovijarvi A Saynajakangas O Pietinalho A. The 10-year COPD Programme in Finland: effects on quality of diagnosis smoking prevalence hospital admissions and mortality. Prim Care Respir J. 2011; 20: 178\u201383. [PubMed Abstract].","DOI":"10.4104\/pcrj.2011.00024"},{"key":"e_1_3_1_54_1","doi-asserted-by":"crossref","unstructured":"Haahtela T Tuomisto LE Pietinalho A Klaukka T Erhola M Kaila M etal. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006; 61: 663\u201370. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1136\/thx.2005.055699"},{"key":"e_1_3_1_55_1","doi-asserted-by":"crossref","unstructured":"Gershon AS Warner L Cascagnette P Victor JC To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011; 378: 991\u20136. [PubMed Abstract].","DOI":"10.1016\/S0140-6736(11)60990-2"}],"container-title":["European Clinical Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3402\/ecrj.v3.31780","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.3402\/ecrj.v3.31780","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3402\/ecrj.v3.31780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:36:36Z","timestamp":1789587396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3402\/ecrj.v3.31780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1,1]]}},"alternative-id":["10.3402\/ecrj.v3.31780"],"URL":"https:\/\/doi.org\/10.3402\/ecrj.v3.31780","relation":{},"ISSN":["2001-8525"],"issn-type":[{"value":"2001-8525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zecr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zecr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-06-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"31780"}}